RLMD
Relmada Therapeutics Inc
NASDAQ: RLMD · HEALTHCARE · BIOTECHNOLOGY
$7.52
+2.04% today
Updated 2026-04-30
Market cap
$759.40M
P/E ratio
—
P/S ratio
9,001.90x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$0 – $8
Volume
2.1M
Relmada Therapeutics Inc (RLMD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7941.00 | $5129.00 | — | — | — | — | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -35.4% | -100.0% | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $5799.00 | $4036.00 | — | $9256.00 | $54819.00 | $85271.00 | $2627.00 | $4870.00 | $3752.00 | $1258.00 | — | — | — | — |
| Gross profit | $2142.00 | $1093.00 | — | $-9256.00 | $-54819.00 | $-85271.00 | $-2627.00 | $-4870.00 | $-3752.00 | $-1258.00 | — | — | — | — |
| Gross margin | 27.0% | 21.3% | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | $5.38M | $7.87M | $7.87M | $6.21M | $1.29M | $2.94M | $7.86M | $35.97M | $90.62M | $113.32M | $54.81M | $46.18M | $744560.00 |
| SG&A | $9090.00 | $45076.00 | $9.23M | $9.23M | $10.01M | $5.93M | $3.98M | $7.25M | $24.87M | $35.08M | $47.93M | $48.90M | $37.72M | $311904.00 |
| Operating income | $-12052.00 | $-45015.00 | $-17.10M | $-17.10M | $-16.22M | $-7.22M | $-6.92M | $-15.11M | $-60.84M | $-125.70M | $-161.25M | $-103.70M | $-83.89M | $-59.10M |
| Operating margin | -151.8% | -877.7% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-11675.00 | $-45015.00 | $-20.79M | $-17.09M | $-16.03M | $-6.92M | $-6.92M | $-15.11M | $-59.33M | $-125.70M | $-161.25M | $4.91M | $-83.89M | $-59.10M |
| EBITDA margin | -147.0% | -877.7% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-12429.00 | $-45388.00 | $-20.80M | $-17.10M | $-16.08M | $-7.01M | $-6.92M | $-15.11M | $-59.34M | $-125.70M | $-161.25M | $-98.79M | $-79.98M | — |
| Interest expense | — | — | $4922.00 | $4922.00 | — | $550.00 | $1.34M | — | $1.40M | $48317.00 | $4.21M | — | — | — |
| Income tax | $-377.00 | $-9.58M | — | $3.70M | $-13.11M | $-716000.00 | $2.05M | $4.59M | $-1.38M | $48317.00 | $-2.66M | $-103702.00 | — | — |
| Effective tax rate | 3.0% | 99.5% | 0.0% | -21.7% | 81.5% | 10.2% | -29.6% | -44.1% | 2.3% | -0.0% | 1.7% | 0.1% | 0.0% | 0.0% |
| Net income | $-12052.00 | $-45015.00 | $-20.80M | $-20.80M | $-2.98M | $-6.29M | $-8.96M | $-15.01M | $-59.46M | $-125.75M | $-157.04M | $-98.79M | $-79.98M | $-57.39M |
| Net income growth (YoY) | — | -273.5% | -46114.8% | -0.0% | +85.7% | -111.3% | -42.5% | -67.4% | -296.2% | -111.5% | -24.9% | +37.1% | +19.0% | +28.3% |
| Profit margin | -151.8% | -877.7% | — | — | — | — | — | — | — | — | — | — | — | — |